鳞癌-话题@MedSci

#鳞癌#

133篇内容 | 3393人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1484682, encodeId=0403148468238, content=<a href='/topic/show?id=3502102944e7' target=_blank style='color:#2F92EE;'>#鳞癌#</a>, objectTitle=欧狄沃（纳武利尤单抗）联合化疗及欧狄沃联合伊匹木单抗治疗晚期不可切除或转移性食管鳞癌患者均可带来显著生存获益, objectType=article, longId=209794, objectId=fb68209e9495, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fb68209e9495, replyNumber=0, likeNumber=0, createdTime=2021-04-12, rootId=0, userName=1696533704_45270456, userId=745a7977375, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fb68209e9495, moduleTitle=欧狄沃（纳武利尤单抗）联合化疗及欧狄沃联合伊匹木单抗治疗晚期不可切除或转移性食管鳞癌患者均可带来显著生存获益, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fb68209e9495)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1484681, encodeId=d66b1484681ec, content=<a href='/topic/show?id=3502102944e7' target=_blank style='color:#2F92EE;'>#鳞癌#</a>, objectTitle=JCO：Tipifarnib对复发和/或转移性头颈鳞癌疗效显著, objectType=article, longId=208966, objectId=e02220896609, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e02220896609, replyNumber=0, likeNumber=69, createdTime=2021-03-26, rootId=0, userName=1696533704_45270456, userId=745a7977375, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e02220896609, moduleTitle=JCO：Tipifarnib对复发和/或转移性头颈鳞癌疗效显著, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e02220896609)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1484680, encodeId=5531148468026, content=<a href='/topic/show?id=3502102944e7' target=_blank style='color:#2F92EE;'>#鳞癌#</a>, objectTitle=J Clin Oncol：低剂量放疗联合顺铂可有效治疗HPV相关性口咽鳞癌, objectType=article, longId=206571, objectId=f4692065e14a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f4692065e14a, replyNumber=0, likeNumber=0, createdTime=2021-02-03, rootId=0, userName=1696533704_45270456, userId=745a7977375, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f4692065e14a, moduleTitle=J Clin Oncol：低剂量放疗联合顺铂可有效治疗HPV相关性口咽鳞癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f4692065e14a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1484679, encodeId=89c414846e9a5, content=<a href='/topic/show?id=3502102944e7' target=_blank style='color:#2F92EE;'>#鳞癌#</a>, objectTitle=免疫治疗头颈部鳞癌一线长生存数据公布, objectType=article, longId=201492, objectId=9afb20149296, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9afb20149296, replyNumber=0, likeNumber=75, createdTime=2020-10-03, rootId=0, userName=1696533704_45270456, userId=745a7977375, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9afb20149296, moduleTitle=免疫治疗头颈部鳞癌一线长生存数据公布, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9afb20149296)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1484678, encodeId=0b8a14846e818, content=<a href='/topic/show?id=3502102944e7' target=_blank style='color:#2F92EE;'>#鳞癌#</a>, objectTitle=Br J Cancer：尼妥珠单抗联合顺铂放疗改善高HIF1α表达的局部晚期头颈部鳞癌患者的预后, objectType=article, longId=201080, objectId=d88e20108084, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d88e20108084, replyNumber=0, likeNumber=61, createdTime=2020-09-24, rootId=0, userName=1696533704_45270456, userId=745a7977375, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d88e20108084, moduleTitle=Br J Cancer：尼妥珠单抗联合顺铂放疗改善高HIF1α表达的局部晚期头颈部鳞癌患者的预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d88e20108084)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1484677, encodeId=04aa14846e7bc, content=<a href='/topic/show?id=3502102944e7' target=_blank style='color:#2F92EE;'>#鳞癌#</a>, objectTitle=基石药业舒格利单抗一线数据亮相ESMO，胃癌、食管鳞癌再迎新突破, objectType=article, longId=201028, objectId=cf56201028f4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cf56201028f4, replyNumber=0, likeNumber=78, createdTime=2020-09-23, rootId=0, userName=1696533704_45270456, userId=745a7977375, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cf56201028f4, moduleTitle=基石药业舒格利单抗一线数据亮相ESMO，胃癌、食管鳞癌再迎新突破, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cf56201028f4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1484676, encodeId=a99114846e6d6, content=<a href='/topic/show?id=3502102944e7' target=_blank style='color:#2F92EE;'>#鳞癌#</a>, objectTitle=围绕四大基本问题构建，原发灶不明的头颈部鳞癌指南的诊断及治疗原则解读, objectType=article, longId=198222, objectId=6802198222f9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6802198222f9, replyNumber=0, likeNumber=77, createdTime=2020-07-30, rootId=0, userName=1696533704_45270456, userId=745a7977375, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6802198222f9, moduleTitle=围绕四大基本问题构建，原发灶不明的头颈部鳞癌指南的诊断及治疗原则解读, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6802198222f9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1484675, encodeId=188014846e582, content=<a href='/topic/show?id=3502102944e7' target=_blank style='color:#2F92EE;'>#鳞癌#</a>, objectTitle=FDA：批准纳武利尤单抗获批食管鳞癌二线治疗, objectType=article, longId=195812, objectId=6d62195812c1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6d62195812c1, replyNumber=0, likeNumber=150, createdTime=2020-06-14, rootId=0, userName=1696533704_45270456, userId=745a7977375, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6d62195812c1, moduleTitle=FDA：批准纳武利尤单抗获批食管鳞癌二线治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6d62195812c1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1484674, encodeId=1ee314846e47c, content=<a href='/topic/show?id=3502102944e7' target=_blank style='color:#2F92EE;'>#鳞癌#</a>, objectTitle=ASCO 2020 | 肺鳞癌免疫治疗新突破，百济神州展现中国“研”值, objectType=article, longId=195059, objectId=f74a195059c2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f74a195059c2, replyNumber=0, likeNumber=71, createdTime=2020-06-02, rootId=0, userName=1696533704_45270456, userId=745a7977375, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f74a195059c2, moduleTitle=ASCO 2020 | 肺鳞癌免疫治疗新突破，百济神州展现中国“研”值, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f74a195059c2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1484673, encodeId=a81214846e35c, content=<a href='/topic/show?id=3502102944e7' target=_blank style='color:#2F92EE;'>#鳞癌#</a>, objectTitle=Oral Oncol：肿瘤相关巨噬细胞可用于预测头颈部鳞癌的预后, objectType=article, longId=194885, objectId=927e19488575, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=927e19488575, replyNumber=0, likeNumber=66, createdTime=2020-05-29, rootId=0, userName=1696533704_45270456, userId=745a7977375, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=927e19488575, moduleTitle=Oral Oncol：肿瘤相关巨噬细胞可用于预测头颈部鳞癌的预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=927e19488575)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1484672, encodeId=e6cb14846e2ad, content=<a href='/topic/show?id=3502102944e7' target=_blank style='color:#2F92EE;'>#鳞癌#</a>, objectTitle=GSK的ICOS单抗联合Keytruda治疗头颈部鳞癌在中国获批临床试验, objectType=article, longId=194392, objectId=102a19439241, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=102a19439241, replyNumber=0, likeNumber=49, createdTime=2020-05-20, rootId=0, userName=1696533704_45270456, userId=745a7977375, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=102a19439241, moduleTitle=GSK的ICOS单抗联合Keytruda治疗头颈部鳞癌在中国获批临床试验, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=102a19439241)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1484671, encodeId=267c14846e106, content=<a href='/topic/show?id=3502102944e7' target=_blank style='color:#2F92EE;'>#鳞癌#</a>, objectTitle=病例：特瑞普利单抗联合化疗新辅助治疗获PR，初始手术困难的食管鳞癌患者成功施行根治术, objectType=article, longId=184375, objectId=b5451843e5d2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b5451843e5d2, replyNumber=0, likeNumber=75, createdTime=2019-12-08, rootId=0, userName=1696533704_45270456, userId=745a7977375, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b5451843e5d2, moduleTitle=病例：特瑞普利单抗联合化疗新辅助治疗获PR，初始手术困难的食管鳞癌患者成功施行根治术, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b5451843e5d2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1484670, encodeId=d01f14846e0b4, content=<a href='/topic/show?id=3502102944e7' target=_blank style='color:#2F92EE;'>#鳞癌#</a>, objectTitle=PD-1单抗单药治疗双原发癌，局部晚期肺鳞癌肿瘤疗效PR，肝细胞癌肿瘤疗效评估pCR, objectType=article, longId=184137, objectId=74cc18413e05, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=74cc18413e05, replyNumber=0, likeNumber=34, createdTime=2019-12-05, rootId=0, userName=1696533704_45270456, userId=745a7977375, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=74cc18413e05, moduleTitle=PD-1单抗单药治疗双原发癌，局部晚期肺鳞癌肿瘤疗效PR，肝细胞癌肿瘤疗效评估pCR, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=74cc18413e05)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1484669, encodeId=604a1484669ef, content=<a href='/topic/show?id=3502102944e7' target=_blank style='color:#2F92EE;'>#鳞癌#</a>, objectTitle=病例:一例纵隔型肺鳞癌的二线免疫治疗, objectType=article, longId=183917, objectId=681618391ec1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=681618391ec1, replyNumber=0, likeNumber=80, createdTime=2019-12-03, rootId=0, userName=1696533704_45270456, userId=745a7977375, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=681618391ec1, moduleTitle=病例:一例纵隔型肺鳞癌的二线免疫治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=681618391ec1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1484668, encodeId=304814846681b, content=<a href='/topic/show?id=3502102944e7' target=_blank style='color:#2F92EE;'>#鳞癌#</a>, objectTitle=中国晚期肺鳞癌患者迎一线治疗新标准，帕博利珠单抗新适应证获批意义重大, objectType=article, longId=183912, objectId=fc8b1839120b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fc8b1839120b, replyNumber=0, likeNumber=56, createdTime=2019-12-03, rootId=0, userName=1696533704_45270456, userId=745a7977375, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fc8b1839120b, moduleTitle=中国晚期肺鳞癌患者迎一线治疗新标准，帕博利珠单抗新适应证获批意义重大, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fc8b1839120b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1484667, encodeId=4919148466e23, content=<a href='/topic/show?id=3502102944e7' target=_blank style='color:#2F92EE;'>#鳞癌#</a>, objectTitle=超声内镜辅助诊断食管鳞癌胃转移1例, objectType=article, longId=182893, objectId=062b182893ac, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=062b182893ac, replyNumber=0, likeNumber=70, createdTime=2019-11-14, rootId=0, userName=1696533704_45270456, userId=745a7977375, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=062b182893ac, moduleTitle=超声内镜辅助诊断食管鳞癌胃转移1例, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=062b182893ac)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1484666, encodeId=479314846662e, content=<a href='/topic/show?id=3502102944e7' target=_blank style='color:#2F92EE;'>#鳞癌#</a>, objectTitle=信迪利单抗联合化疗用于晚期肺鳞癌二线治疗，肿瘤持续缓解7个月以上, objectType=article, longId=181304, objectId=4eaa18130437, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4eaa18130437, replyNumber=0, likeNumber=75, createdTime=2019-10-17, rootId=0, userName=1696533704_45270456, userId=745a7977375, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4eaa18130437, moduleTitle=信迪利单抗联合化疗用于晚期肺鳞癌二线治疗，肿瘤持续缓解7个月以上, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4eaa18130437)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1484665, encodeId=2ca614846654d, content=<a href='/topic/show?id=3502102944e7' target=_blank style='color:#2F92EE;'>#鳞癌#</a>, objectTitle=【ESMO速递】晚期食管鳞癌研究进展，免疫治疗再下一城, objectType=article, longId=181104, objectId=dde918110499, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dde918110499, replyNumber=0, likeNumber=78, createdTime=2019-10-15, rootId=0, userName=1696533704_45270456, userId=745a7977375, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dde918110499, moduleTitle=【ESMO速递】晚期食管鳞癌研究进展，免疫治疗再下一城, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dde918110499)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1484664, encodeId=a79d14846647f, content=<a href='/topic/show?id=3502102944e7' target=_blank style='color:#2F92EE;'>#鳞癌#</a>, objectTitle=【2019 ESMO】放化疗联合帕博利珠单抗治疗局部晚期食管鳞癌, objectType=article, longId=181035, objectId=c7c318103504, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c7c318103504, replyNumber=0, likeNumber=83, createdTime=2019-10-14, rootId=0, userName=1696533704_45270456, userId=745a7977375, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c7c318103504, moduleTitle=【2019 ESMO】放化疗联合帕博利珠单抗治疗局部晚期食管鳞癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c7c318103504)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1484663, encodeId=fe7c148466310, content=<a href='/topic/show?id=3502102944e7' target=_blank style='color:#2F92EE;'>#鳞癌#</a>, objectTitle=单抗联合化疗新辅助治疗食管鳞癌, objectType=article, longId=180797, objectId=c857180e973c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c857180e973c, replyNumber=0, likeNumber=119, createdTime=2019-10-11, rootId=0, userName=1696533704_45270456, userId=745a7977375, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c857180e973c, moduleTitle=单抗联合化疗新辅助治疗食管鳞癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c857180e973c)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

鳞癌

2020-05-29

1696533704_45270456 (审核中...)

前往app查看评论内容

#鳞癌#

欧狄沃（纳武利尤单抗）联合化疗及欧狄沃联合伊匹木单抗治疗晚期不可切除或转移性食管鳞癌患者均可带来显著生存获益

2021-04-12

1696533704_45270456 (审核中...)

前往app查看评论内容

#鳞癌#

JCO：Tipifarnib对复发和/或转移性头颈鳞癌疗效显著

2021-03-26

1696533704_45270456 (审核中...)

前往app查看评论内容

#鳞癌#

J Clin Oncol：低剂量放疗联合顺铂可有效治疗HPV相关性口咽鳞癌

2021-02-03

1696533704_45270456 (审核中...)

前往app查看评论内容

#鳞癌#

免疫治疗头颈部鳞癌一线长生存数据公布

2020-10-03

1696533704_45270456 (审核中...)

前往app查看评论内容

#鳞癌#

Br J Cancer：尼妥珠单抗联合顺铂放疗改善高HIF1α表达的局部晚期头颈部鳞癌患者的预后

2020-09-24

1696533704_45270456 (审核中...)

前往app查看评论内容

#鳞癌#

基石药业舒格利单抗一线数据亮相ESMO，胃癌、食管鳞癌再迎新突破

2020-09-23

1696533704_45270456 (审核中...)

前往app查看评论内容

#鳞癌#

围绕四大基本问题构建，原发灶不明的头颈部鳞癌指南的诊断及治疗原则解读

2020-07-30

1696533704_45270456 (审核中...)

前往app查看评论内容

#鳞癌#

FDA：批准纳武利尤单抗获批食管鳞癌二线治疗

2020-06-14

1696533704_45270456 (审核中...)

前往app查看评论内容

#鳞癌#

ASCO 2020 | 肺鳞癌免疫治疗新突破，百济神州展现中国“研”值

2020-06-02

1696533704_45270456 (审核中...)

前往app查看评论内容

#鳞癌#

Oral Oncol：肿瘤相关巨噬细胞可用于预测头颈部鳞癌的预后

2020-05-29

1696533704_45270456 (审核中...)

前往app查看评论内容

#鳞癌#

GSK的ICOS单抗联合Keytruda治疗头颈部鳞癌在中国获批临床试验

2020-05-20

1696533704_45270456 (审核中...)

前往app查看评论内容

#鳞癌#

病例：特瑞普利单抗联合化疗新辅助治疗获PR，初始手术困难的食管鳞癌患者成功施行根治术

2019-12-08

1696533704_45270456 (审核中...)

前往app查看评论内容

#鳞癌#

PD-1单抗单药治疗双原发癌，局部晚期肺鳞癌肿瘤疗效PR，肝细胞癌肿瘤疗效评估pCR

2019-12-05

1696533704_45270456 (审核中...)

前往app查看评论内容

#鳞癌#

病例:一例纵隔型肺鳞癌的二线免疫治疗

2019-12-03

1696533704_45270456 (审核中...)

前往app查看评论内容

#鳞癌#

中国晚期肺鳞癌患者迎一线治疗新标准，帕博利珠单抗新适应证获批意义重大

2019-12-03

1696533704_45270456 (审核中...)

前往app查看评论内容

#鳞癌#

超声内镜辅助诊断食管鳞癌胃转移1例

2019-11-14

1696533704_45270456 (审核中...)

前往app查看评论内容

#鳞癌#

信迪利单抗联合化疗用于晚期肺鳞癌二线治疗，肿瘤持续缓解7个月以上

2019-10-17

1696533704_45270456 (审核中...)

前往app查看评论内容

#鳞癌#

【ESMO速递】晚期食管鳞癌研究进展，免疫治疗再下一城

2019-10-15

1696533704_45270456 (审核中...)

前往app查看评论内容

#鳞癌#

【2019 ESMO】放化疗联合帕博利珠单抗治疗局部晚期食管鳞癌

2019-10-14

1696533704_45270456 (审核中...)

前往app查看评论内容

#鳞癌#

单抗联合化疗新辅助治疗食管鳞癌

2019-10-11

科室
- - 订阅+
  - 更多科室
工具
服务